Assyro AI

Orange Book product · Brand (NDA)

VIBATIV

TELAVANCIN HYDROCHLORIDE

Brand (NDA)NDA 022110RX CUMBERLAND

At a glance

Sep 11, 2009

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 11, 2009

    17 yr ago

  2. Today

  3. Patent 7531623 expires

    Listed drug substance patent expiration.

    Jan 01, 2027

    in 7 mo

Pharmaceutical detail

Active ingredient

TELAVANCIN HYDROCHLORIDE

Strength

EQ 750MG BASE/VIAL

Dosage form

POWDER

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 022110

Product number

002

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7531623Jan 01, 2027in 7 mo
Substance
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.